T-cell cytokine induction of BMP-2 regulates human mesenchymal stromal cell differentiation and mineralization

Journal of Cellular Biochemistry

Volumn 98, Issue 4, 2006, Pages 706-714

  Rifas, Leonard ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Arthritides; Heterotopic ossification; MAP kinase; Matrix mineralization

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; CYTOKINE; DEXAMETHASONE; GAMMA INTERFERON; INTERLEUKIN 17; MITOGEN ACTIVATED PROTEIN KINASE P38; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME INHIBITION; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; INFLAMMATORY DISEASE; MESENCHYME; MINERALIZATION; OSSIFICATION; OSTEOBLAST; PHENOTYPE; PRIORITY JOURNAL; PROTEIN INDUCTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

ARTHRITIS; BONE MARROW CELLS; BONE MORPHOGENETIC PROTEINS; CALCINOSIS; CELL DIFFERENTIATION; CELL MOVEMENT; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; CYTOKINES; HUMANS; INFLAMMATION; SIGNAL TRANSDUCTION; STROMAL CELLS; T-LYMPHOCYTES; TISSUE DONORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 33745631250     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.20933     Document Type: Article

References (41)

1. Boyle LH, Goodall JC, Gaston JS. 2004. The recognition of abnormal forms of HLA-B27 by CD4+ T-cells. Curr Mol Med 4:51-58.
2. Bunger MH, Langdahl BL, Andersen T, Husted L, Lind M, Eriksen EF, Bunger CE. 2003. Semiquantitative mRNA measurements of osteoinductive growth factors in human iliac-crest bone: Expression of LMP splice variants in human bone. Calcif Tissue Int 73:446-454.
3. Cao D, van Vollenhoven R, Klareskog L, Trollmo C, Malmstrom V. 2004. CD25 bright CD4+ regulatory T-cells are enriched in inflamed joints of patients with chronic rheumatic disease. Arthritis Res Ther 6:R335-R346.
4. Cenci S, Weitzmann MN, Roggia C, Namba N, Novack D, Woodring J, Pacifici R. 2000. Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha. J Clin Invest 106:1229-1237.
5. Cenci S, Toraldo G, Weitzmann MN, Roggia C, Gao Y, Qian WP, Sierra O, Pacifici R. 2003. Estrogen deficiency induces bone loss by increasing T-cell proliferation and lifespan through IFN-{gamma}-induced class II transactivator. Proc Natl Acad Sci USA 100:10405-10410.
6. Chabaud M, Miossec P. 2001. The combination of tumor necrosis factor alpha blockade with interleukin-1 and interleukin-17 blockade is more effective for controlling synovial inflammation and bone resorption in an ex vivo model. Arthritis Rheum 44:1293-1303.
7. Cheng SL, Yang JW, Rifas L, Zhang SF, Avioli LV. 1994. Differentiation of human bone marrow osteogenic stromal cells in vitro: Induction of the osteoblast phenotype by dexamethasone. Endocrinology 134:277-286.
8. Clowes JA, Riggs BL, Khosla S. 2005. The role of the immune system in the pathophysiology of osteoporosis. Immunol Rev 208:207-227.
9. Fox SW, Chambers TJ. 2000. Interferon-gamma directly inhibits TRANCE-induced osteoclastogenesis. Biochem Biophys Res Commun 276:868-872.
10. Gerstenfeld LC, Cho TJ, Kon T, Aizawa T, Cruceta J, Graves BD, Einhorn TA. 2001. Impaired intramembranous bone formation during bone repair in the absence of tumor necrosis factor-alpha signaling. Cells Tissues Organs 169:285-294.
11. Gilbert L, He X, Farmer P, Rubin J, Drissi H, van Wijnen AJ, Lian JB, Stein GS, Nanes MS. 2002. Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) is inhibited by tumor necrosis factor-alpha. J Biol Chem 277:2695-2701.
12. Goronzy JJ, Weyand CM. 2004. T-cell regulation in rheumatoid arthritis. Curr Opin Rheumatol 16:212-217.
13. Gough AK, Peel NF, Eastell R, Holder RL, Lilley J, Emery P. 1994. Excretion of pyridinium crosslinks correlates with disease activity and appendicular bone loss in early rheumatoid arthritis. Ann Rheum Dis 53:14-17.
14. Guicheux J, Lemonnier J, Ghayor C, Suzuki A, Palmer G, Caverzasio J. 2003. Activation of p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation. J Bone Miner Res 18:2060-2068.
15. Huang W, Schwarz EM. 2002. Mechanisms of bone resorption and new bone formation in spondyloarthropathies. Curr Rheumatol Rep 4:513-517.
16. Imanishi D, Yamamoto K, Tsushima H, Miyazaki Y, Kuriyama K, Tomonaga M, Matsuyama T. 2000. Identification of a novel cytokine response element in the human IFN regulatory factor-1 gene promoter. J Immunol 165:3907-3916.
17. Kamolmatyakul S, Chen W, Li YP. 2001. Interferon-gamma downregulates gene expression of cathepsin K in osteoclasts and inhibits osteoclast formation. J Dent Res 80:351-355.
18. Katagiri T, Takahashi N. 2002. Regulatory mechanisms of osteoblast and osteoclast differentiation. Oral Dis 8:147-159.
19. Kon T, Cho TJ, Aizawa T, Yamazaki M, Nooh N, Graves D, Gerstenfeld LC, Einhorn TA. 2001. Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing. J Bone Miner Res 16:1004-1014.
20. Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, Ishiyama S, Saito S, Inoue K, Kamatani N, Gillespie MT, Martin TJ, Suda T. 1999. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 103:1345-1352.
21. Lee KS, Hong SH, Bae SC. 2002. Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor-beta and bone morphogenetic protein. Oncogene 21:7156-7163.
22. Lettesjo H, Nordstrom E, Strom H, Nilsson B, Glinghammar B, Dahlstedt L, Moller E. 1998. Synovial fluid cytokines in patients with rheumatoid arthritis or other arthritic lesions. Scand J Immunol 48:286-292.
23. Luppen CA, Smith E, Spevak L, Boskey AL, Frenkel B. 2003. Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures. J Bone Miner Res 18:1186-1197.
24. Miossec P. 2000. Are T-cells in rheumatoid synovium aggressors or bystanders? Curr Opin Rheumatol 12:181-185.
25. Miossec P. 2004. An update on the cytokine network in rheumatoid arthritis. Curr Opin Rheumatol 16:218-222.
26. Noth U, Tuli R, Seghatoleslami R, Howard M, Shah A, Hall DJ, Hickok NJ, Tuan RS. 2003. Activation of p38 and Smads mediates BMP-2 effects on human trabecular bone-derived osteoblasts. Exp Cell Res 291:201-211.
27. Park SY, Seol JW, Lee YJ, Cho JH, Kang HS, Kim IS, Park SH, Kim TH, Yim JH, Kim M, Billiar TR, Seol DW. 2004. IFN-gamma enhances TRAIL-induced apoptosis through IRF-1. Eur J Biochem 271:4222-4228.
28. Prabhakar U, James IE, Dodds RA, Lee-Rykaczewski E, Rieman DJ, Lipshutz D, Trulli S, Jonak Z, Tan KB, Drake FH, Gowen M. 1998. A novel human bone marrow stroma-derived cell line TF274 is highly osteogenic in vitro and in vivo. Calcif Tissue Int 63:214-220.
29. Rifas L, Arackal S. 2003. T-cells regulate the expression of matrix metalloproteinase in human osteoblasts via a dual mitogen-activated protein kinase mechanism. Arthritis Rheum 48:993-1001.
30. Rifas L, Kenney JS, Marcelli M, Pacifici R, Cheng SL, Dawson LL, Avioli LV. 1995. Production of interleukin-6 in human osteoblasts and human bone marrow stromal cells: Evidence that induction by interleukin-1 and tumor necrosis factor-alpha is not regulated by ovarian steroids. Endocrinology 136:4056-4067.
31. Rifas L, Arackal S, Weitzmann MN. 2003. Inflammatory T-cells rapidly induce differentiation of human bone marrow stromal cells into mature osteoblasts. J Cell Biochem 88:650-659.
32. Spinella-Jaegle S, Roman-Roman S, Faucheu C, Dunn FW, Kawai S, Gallea S, Stiot V, Blanchet AM, Courtois B, Baron R, Rawadi G. 2001. Opposite effects of bone morphogenetic protein-2 and transforming growth factor-beta1 on osteoblast differentiation. Bone 29:323-330.
33. Stamp LK, James MJ, Cleland LG. 2004. Interleukin-17: The missing link between T-cell accumulation and effector cell actions in rheumatoid arthritis? Immunol Cell Biol 82:1-9.
34. Stanford CM, Jacobson PA, Eanes ED, Lembke LA, Midura RJ. 1995. Rapidly forming apatitic mineral in an osteoblastic cell line (UMR 106-01 BSP). J Biol Chem 270:9420-9428.
35. Steiner G, Tohidast-Akrad M, Witzmann G, Vesely M, Studnicka-Benke A, Gal A, Kunaver M, Zenz P, Smolen JS. 1999. Cytokine production by synovial T-cells in rheumatoid arthritis. Rheumatology (Oxford) 38:202-213.
36. Suzuki M, Takahashi M, Miyamoto S, Hoshino H, Kushida K, Miura M, Inoue T. 1998. The effects of menopausal status and disease activity on biochemical markers of bone metabolism in female patients with rheumatoid arthritis. Br J Rheumatol 37:653-658.
37. van Bezooijen RL, Farih-Sips HC, Papapoulos SE, Lowik CW. 1999. Interleukin-17: A new bone acting cytokine in vitro. J Bone Miner Res 14:1513-1521.
38. Weitzmann MN, Cenci S, Rifas L, Haug J, Dipersio J, Pacifici R. 2001a. T-cell activation induces human osteoclast formation via receptor activator of nuclear factor kappaB ligand-dependent and -independent mechanisms. J Bone Miner Res 16:328-337.
39. Weitzmann MN, Cenci S, Rifas L, Haug J, Dipersio J, Pacifici R. 2001b. T-cell activation induces human osteoclast formation via receptor activator of nuclear factor kappaB ligand-dependent and -independent mechanisms. J Bone Miner Res 16:328-337.
40. Yang S, Madyastha P, Ries W, Key LL. 2002. Characterization of interferon gamma receptors on osteoclasts: Effect of interferon gamma on osteoclastic superoxide generation. J Cell Biochem 84:645-654.
41. Ziolkowska M, Koc A, Luszczykiewicz G, Ksiezopolska-Pietrzak K, Klimczak E, Chwalinska-Sadowska H, Maslinski W. 2000. High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J Immunol 164:2832-2838.